TY - JOUR
T1 - Topical Cannabidiol Application May Not Attenuate Muscle Soreness or Improve Performance
T2 - A Randomized, Double-Blinded, Placebo-Controlled Pilot Study
AU - Pastina, Joseph T.
AU - Abel, Mark
AU - Bollinger, Lance M.
AU - Best, Stuart
N1 - Publisher Copyright:
© Mary Ann Liebert, Inc.
PY - 2024
Y1 - 2024
N2 - Purpose: The purpose of this pilot study was to investigate cannabidiol (CBD) cream’s effects on muscle soreness and performance after exercise. Materials and Methods: This double-blinded, placebo-controlled experiment included 15 men and 13 women (n = 28; mean – standard deviation age: 23.29 – 2.54 years) untrained in lower-body resistance training. Participants were randomized into control (NG, n = 9), CBD (CG, n = 9), or placebo (PG, n = 10) groups. Participants completed a lower-body fatigue protocol (FP) consisting of unilateral maximal concentric and eccentric isokinetic muscle actions of the quadriceps and hamstrings (5 sets, 10 repetitions, both legs). CG and PG participants applied *100 mg CBD or placebo cream, respectively, matched for weight and appearance to the quadriceps on three separate days. NG participants engaged in a sitting rest period matched in duration to cream application processes. Questionnaires, pressure–pain threshold (PPT), peak torque test (PTT), and countermovement jump (CMJ) were assessed. Mixed-model analysis of variance was conducted to assess main effects and interactions (group · muscle · time; group · time). Results: There were no significant interactions or main effects for group for PPT, CMJ, or PTT. There were main effects for time (p < 0.05) for all soreness questions, PPT, CMJ, and PTT. There was one significant interaction (group · time; p = 0.045) for cream/rest effect questions, in which PG participants perceived the effect of cream to be greater than the effect of rest for NG participants. There were main effects for group (p £ 0.031) for all soreness questions, in which PG participants perceived enhanced recovery. Conclusions: The present pilot study did not discover any significant impacts of CBD cream use for muscle recovery. For individuals seeking to attenuate muscle soreness and improve performance, the current dose of this topical CBD product may not be an effective treatment.
AB - Purpose: The purpose of this pilot study was to investigate cannabidiol (CBD) cream’s effects on muscle soreness and performance after exercise. Materials and Methods: This double-blinded, placebo-controlled experiment included 15 men and 13 women (n = 28; mean – standard deviation age: 23.29 – 2.54 years) untrained in lower-body resistance training. Participants were randomized into control (NG, n = 9), CBD (CG, n = 9), or placebo (PG, n = 10) groups. Participants completed a lower-body fatigue protocol (FP) consisting of unilateral maximal concentric and eccentric isokinetic muscle actions of the quadriceps and hamstrings (5 sets, 10 repetitions, both legs). CG and PG participants applied *100 mg CBD or placebo cream, respectively, matched for weight and appearance to the quadriceps on three separate days. NG participants engaged in a sitting rest period matched in duration to cream application processes. Questionnaires, pressure–pain threshold (PPT), peak torque test (PTT), and countermovement jump (CMJ) were assessed. Mixed-model analysis of variance was conducted to assess main effects and interactions (group · muscle · time; group · time). Results: There were no significant interactions or main effects for group for PPT, CMJ, or PTT. There were main effects for time (p < 0.05) for all soreness questions, PPT, CMJ, and PTT. There was one significant interaction (group · time; p = 0.045) for cream/rest effect questions, in which PG participants perceived the effect of cream to be greater than the effect of rest for NG participants. There were main effects for group (p £ 0.031) for all soreness questions, in which PG participants perceived enhanced recovery. Conclusions: The present pilot study did not discover any significant impacts of CBD cream use for muscle recovery. For individuals seeking to attenuate muscle soreness and improve performance, the current dose of this topical CBD product may not be an effective treatment.
KW - cannabis
KW - CBD
KW - cream
KW - DOMS
KW - EIMD
UR - http://www.scopus.com/inward/record.url?scp=85198979099&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85198979099&partnerID=8YFLogxK
U2 - 10.1089/can.2024.0012
DO - 10.1089/can.2024.0012
M3 - Article
C2 - 38980809
AN - SCOPUS:85198979099
SN - 2378-8763
JO - Cannabis and Cannabinoid Research
JF - Cannabis and Cannabinoid Research
ER -